Replies to post #56060 on DNAprint Genomics (DNAG)

[gunnabeoneday]

so now the measuring stick has been raised to "a legitimate press release from DNAG, Merck or Moffitt stating that DNAG is indeed a joint member of the M2GEN deal"

a joint member...

you really are a piece of work.



btw, are you ready to respond to worktoplay's post 55886 to you yet?

here, in case you didn't notice it:

http://www.investorshub.com/boards/read_msg.asp?message_id=16768406



Posted by: worktoplay
In reply to: dr frudaky who wrote msg# 55826 Date:2/4/2007 4:57:52 PM
Post #of 56061

There haven't been "press releases", but there clearly have been results. Here is just one example, ondansetron results, which were only recently presented at the annual meeting of the American Society of Anesthesiologists on October 15, 2006:

http://www.asaabstracts.com/strands/asaabstracts/abstract.htm;jsessionid=C8F2EDAAE628B56E3A987BFE175....

In fact, far from Moffitt distancing themselves from DNAPrint, the "Discussion" contained in the abstract indicates that there will be further collaboration between the Moffitt and DNAPrint researchers with respect to ondansetron:

Discussion

Overall, our findings are consistent with previous reports for the incidence of PONV and response to treatment. We have found an association between SNPs and PONV that appear consistent with the pharmacology of the PONV triggering medications. All of the SNPs with p< 0.05 values will be tested in a validation study with independent subjects to identify which genes and SNP variants are predictors of PONV and the efficacy of Ondansetron.

I would also point out that this project wasn't even included in the original agreement, but was added for some reason. Tell me Doc, if the platform was not producing results in the originally intended areas, why would Moffitt expand it's use into other indications?

Thanks to mingwan0 for the link which he posted some time back on the Nap Heads II board.

Later,
W2P

[Gcbr]

what ever fud. I posted facts. If you can not deal with it
Eugene so be it.